Retracted: Innovative Therapies against Human Glioblastoma Multiforme
International Scholarly Research Notices has retracted the article titled “Innovative Therapies against Human Glioblastoma Multiforme” . The article was found to contain a substantial amount of material from previously published articles, including the following sources:
(i) Lefranc F., Facchini V., and Kiss R. (2007): “Proautophagic Drugs: A novel Means to Combat Apoptosis-Resistant Cancers, with a Special Emphasis on Glioblastomas,” Oncologist 12, 1395–1403, https://doi.org/10.1634%2ftheoncologist.12-12-1395  (cited as ).
(ii) Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, and Stegh A, et al.: “Malignant Astrocytic Glioma: Genetics, Biology, and Paths to Treatment,” Genes Dev 2007;21:2683–710, https://doi.org/10.1101/gad.1596707, Genes & Dev. 2007. 21: 2683-2710  (not cited).
(iii) Elisabetta Benedetti: “PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors,” PPAR Research, 2010, https://doi.org/10.1155%2f2010%2f427401  (cited as ).
(v) Azizul Haque: “Emerging Role of Combination of All-Trans Retinoic Acid and Interferon-gamma as Chemoimmunotherapy in the Management of Human Glioblastoma,” Neurochemical Research, 11/01/2007, https://doi.org/10.1007%2fs11064-007-9420-z  (cited as ).
F. B. Furnari, T. Fenton, R. M. Bachoo, A. Mukasa, J. M. Stommel, A. Stegh et al., “Malignant astrocytic glioma: genetics, biology, and paths to treatment,” Genes & Development, vol. 21, pp. 2683–2710, 2007.View at: Google Scholar